Medical Device Development Process, and Associated Risks and Legislative Aspects-Systematic Review

Abstract

Objective: Medical device development, from the product's conception to release to market, is very complex and relies significantly on the application of exact processes. This paper aims to provide an analysis and summary of current research in the field of medical device development methodologies, discuss its phases, and evaluate the associated legislative and risk aspects. Methods: The literature search was conducted to detect peer-reviewed studies in Scopus, Web of Science, and Science Direct, on content published between 2007 and November 2019. Based on exclusion and inclusion criteria, 13 papers were included in the first session and 11 were included in the second session. Thus, a total of 24 papers were analyzed. Most of the publications originated in the United States (7 out of 24). Results: The medical device development process comprises one to seven stages. Six studies also contain a model of the medical device development process for all stages or for just some of the stages. These studies specifically describe the concept stage during which all uncertainties, such as the clinical need definition, customer requirements/needs, finances, reimbursement strategy, team selection, and legal aspects, must be considered. Conclusion: The crucial factor in healthcare safety is the stability of factors over a long production time. Good manufacturing practices cannot be tested on individual batches of products; they must be inherently built into the manufacturing process. The key issues that must be addressed in the future are the consistency in the classification of devices throughout the EU and globally, and the transparency of approval processes.

The RAIS Device for Global Surgery: Using a Participatory Design Approach to Navigate the Translational Pathway to Clinical Use

“…The Over-Arching Approach: used to navigate development and clinical translation of the RAIS device was necessarily bespoke, since no over-arching framework exists for the specific needs of developing medical devices for low resource settings, in stark contrast to the multitude which target devices for high resource settings [44] . Here, a composite framework was formed by augmenting the Design for Safe Surgery Roadmap [21] with approaches selected from the literature which aligned with the principles of Participatory Design.…”

Osteochondral tissue engineering: Perspectives for clinical application and preclinical development

“…The product lifecycle of medical devices typically follow five phases: Opportunity phase (where clinical needs are identified), concept and feasibility phase (when the feasibility of innovation development is assessed), verification and validation phase (when the innovation is verified with in vitro and/or in vivo models), product launch preparation phase (where manufacturing and quality control according to Good Manufacturing Practices are implemented) and product launch phase (where market sales and post market surveillance is conducted) [ 110 ]. To ensure that the final product has strong clinical applicability and quality, it is essential that experimental studies in the initial phase to be assessed for quality and integrity [ 111 ].…”

Factors Influencing Private Hospitals’ Participation in the Innovation of Biomedical Engineering Industry: A Perspective of Evolutionary Game Theory

“…Guzzo, D. et al took the application of coalbed methane in the medical device industry as an example to discuss the sustainable recycling business model of the medical device industry [15]. Maresova, P. et al provided an analysis and summary of current research in the field of medical device development methodology through a literature review [16]. Some scholars also discussed the impact of medical policies on the innovation of the BME industry.…”